Statistics
Publications
46
Citations
4K
H-Index
28
Active since
1996
Darryl B. McConnell is an author at Boehringer Ingelheim (Austria) specializing in medicinal chemistry, drug discovery, and oncology.
Publications per year
1996–2024
46
46
Pan-KRAS inhibitor disables oncogenic signalling and tumour growth
Dong-Sung Kim, Lorenz Herdeis, Dorothea Rudolph et al. · Nature · 2023 · 497 citations · Full text
Medicine, Oncology, Pharmacology +17
Drugging an undruggable pocket on KRAS
Dirk Kessler, Michael Gmachl, Andreas Mantoulidis et al. · Proceedings of the National Academy of Sciences · 2019 · 434 citations · Full text
Structure-Based Design of an in Vivo Active Selective BRD9 Inhibitor
Laetitia J. Martin, Manfred Koegl, Gerd Bader et al. · Journal of Medicinal Chemistry · 2016 · 224 citations · Full text
Chemically Induced Degradation of the Oncogenic Transcription Factor BCL6
Nina Kerres, Steffen Steurer, Stefanie Schlager et al. · Cell Reports · 2017 · 206 citations · Full text
1–5 of 46